An underground economy for unapproved slimming drugs is propelled by TikTok fitness influencers and sellers on communication apps, based on recent findings.
The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Viewers are encouraged to contact these profiles directly for supplier links, while also receiving promotional offers.
Additionally, a flourishing market exists on messaging services, where communities with numerous of participants share “before and after” photos, injection guides and claims of next-day British shipping. Sellers market the substance there before directing customers to WhatsApp for purchases.
This medication is an investigational injection created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could assist patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Nevertheless, physicians and chemists have warned that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could lead to users administering substances of unknown origin.
Several experts said the popularity for retatrutide could be linked to the increasing cost of licensed slimming products such as Mounjaro.
Marketing the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for human use under the British medical regulations.
Some influencers try to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still breach pharmaceutical, advertising, and consumer laws, potentially leading to fines, prosecution or imprisonment.
Based on the social media company, the service has taken down problematic content and prohibited associated keywords and search suggestions. The organization stated it was committed to keeping the service safe and investing in enhancing enforcement strategies.
Investigations also discovered groups with up to 9,000 participants selling the experimental drug using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” instantly displays groups with thousands of users, populated with images of slimming results, positive testimonials and step-by-step instructions for preparing or administering at home.
After moments of entering one community, a vendor posted contact information, where most transactions occur. The vendor provided an instruction manual and promised delivery within 48 hours. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about weight, medical conditions or previous experience.
Inside these communities, posts show dark colored packages with Royal Mail labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at residence with sterile water, or ready-to-use pens typically priced at 160 pounds for 20mg. When questioned how long a injector should be used, vendors give conflicting answers varying between a few weeks to “depends on your body”.
A spokesperson for the messaging service stated it regularly monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
“People are administering substances they cannot confirm. Even if the research behind this drug is valid, these online versions may not contain what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service connected the surge in interest to recent cost increases for approved slimming drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.
Her staff has previously encountered individuals harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These materials could be impure or improperly measured.”
A representative from Eli Lilly said the substance was in third stage research studies and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company experimental product not yet authorized … may subject users to possibly significant health risks”.
Eva de Vries is a passionate book lover and local writer from Eindhoven.
